In recent years, China's new material intermediates and pharmaceutical intermediates industry has been continuously transforming towards greener, higher-end, and smarter production. Many enterprises have deepened collaborations with universities and research institutions, persistently developing new processes and products. While reducing production costs, they have also enhanced product quality, gradually aligning product standards with international benchmarks to meet the requirements of European and American pharmacopoeias and ISO quality management systems. The overall competitiveness of the industry has significantly improved.